These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20595227)

  • 1. Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.
    Stathopoulos GT; Sherrill TP; Karabela SP; Goleniewska K; Kalomenidis I; Roussos C; Fingleton B; Yull FE; Peebles RS; Blackwell TS
    Am J Respir Crit Care Med; 2010 Nov; 182(10):1273-81. PubMed ID: 20595227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial impact of CCL2 and CCL12 neutralization on experimental malignant pleural effusion.
    Marazioti A; Kairi CA; Spella M; Giannou AD; Magkouta S; Giopanou I; Papaleonidopoulos V; Kalomenidis I; Snyder LA; Kardamakis D; Stathopoulos GT
    PLoS One; 2013; 8(8):e71207. PubMed ID: 23967166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-17 inhibits development of malignant pleural effusion via interleukin-9-dependent mechanism.
    Lu Y; Lin H; Zhai K; Wang X; Zhou Q; Shi H
    Sci China Life Sci; 2016 Dec; 59(12):1297-1304. PubMed ID: 27535421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study.
    Psallidas I; Karabela SP; Moschos C; Sherrill TP; Kollintza A; Magkouta S; Theodoropoulou P; Roussos C; Blackwell TS; Kalomenidis I; Stathopoulos GT
    Mol Cancer; 2010 Mar; 9():56. PubMed ID: 20219102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.
    Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y
    Front Immunol; 2021; 12():760683. PubMed ID: 34966384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha promotes malignant pleural effusion.
    Stathopoulos GT; Kollintza A; Moschos C; Psallidas I; Sherrill TP; Pitsinos EN; Vassiliou S; Karatza M; Papiris SA; Graf D; Orphanidou D; Light RW; Roussos C; Blackwell TS; Kalomenidis I
    Cancer Res; 2007 Oct; 67(20):9825-34. PubMed ID: 17942913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion.
    Psallidas I; Stathopoulos GT; Maniatis NA; Magkouta S; Moschos C; Karabela SP; Kollintza A; Simoes DC; Kardara M; Vassiliou S; Papiris SA; Roussos C; Kalomenidis I
    Oncogene; 2013 Jan; 32(4):528-35. PubMed ID: 22370646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.
    Yeh HH; Lai WW; Chen HH; Liu HS; Su WC
    Oncogene; 2006 Jul; 25(31):4300-9. PubMed ID: 16518408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
    Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
    J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 promotes malignant pleural effusion in mice by regulating T
    Wu XZ; Zhai K; Yi FS; Wang Z; Wang W; Wang Y; Pei XB; Shi XY; Xu LL; Shi HZ
    Eur J Immunol; 2019 Apr; 49(4):653-665. PubMed ID: 30695099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronic acid is effective against experimental malignant pleural effusion.
    Stathopoulos GT; Moschos C; Loutrari H; Kollintza A; Psallidas I; Karabela S; Magkouta S; Zhou Z; Papiris SA; Roussos C; Kalomenidis I
    Am J Respir Crit Care Med; 2008 Jul; 178(1):50-9. PubMed ID: 18388351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17A-Producing γδT Cells Inhibit the Formation of Malignant Pleural Effusions.
    Wei XS; Pei XB; Liu YL; Wu XZ; Shi HZ; Zhou Q
    Am J Respir Cell Mol Biol; 2019 Aug; 61(2):174-184. PubMed ID: 30608868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.
    Ma X; Yao Y; Yuan D; Liu H; Wang S; Zhou C; Song Y
    PLoS One; 2012; 7(12):e53449. PubMed ID: 23285296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion.
    Guo M; Wu F; Hu G; Chen L; Xu J; Xu P; Wang X; Li Y; Liu S; Zhang S; Huang Q; Fan J; Lv Z; Zhou M; Duan L; Liao T; Yang G; Tang K; Liu B; Liao X; Tao X; Jin Y
    Sci Transl Med; 2019 Jan; 11(474):. PubMed ID: 30626714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinoma.
    Yeh HH; Chang WT; Lu KC; Lai WW; Liu HS; Su WC
    PLoS One; 2013; 8(9):e75287. PubMed ID: 24086497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine/Chemokine/Growth Factor Levels in Malignant Pleural Effusion of Non-small Cell Lung Cancer.
    Hayama N; Hattori S; Takahashi G; Takahashi F; Takeuchi T; Tanaka J; Horio Y; Takiguchi H; Tomomatsu K; Kitahara A; Takihara T; Niimi K; Oguma T; Asano K
    Tokai J Exp Clin Med; 2020 Dec; 45(4):224-229. PubMed ID: 33300594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian target of rapamycin (mTOR) inhibition does not prevent lung adenocarcinoma-induced malignant pleural effusion.
    Vazakidou ME; Magkouta S; Moschos C; Kalomenidis I
    Respirology; 2014 Feb; 19(2):290-292. PubMed ID: 23819792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of Th1 and Th17 cells in murine models of malignant pleural effusion.
    Lin H; Tong ZH; Xu QQ; Wu XZ; Wang XJ; Jin XG; Ma WL; Cheng X; Zhou Q; Shi HZ
    Am J Respir Crit Care Med; 2014 Mar; 189(6):697-706. PubMed ID: 24410406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast cells mediate malignant pleural effusion formation.
    Giannou AD; Marazioti A; Spella M; Kanellakis NI; Apostolopoulou H; Psallidas I; Prijovich ZM; Vreka M; Zazara DE; Lilis I; Papaleonidopoulos V; Kairi CA; Patmanidi AL; Giopanou I; Spiropoulou N; Harokopos V; Aidinis V; Spyratos D; Teliousi S; Papadaki H; Taraviras S; Snyder LA; Eickelberg O; Kardamakis D; Iwakura Y; Feyerabend TB; Rodewald HR; Kalomenidis I; Blackwell TS; Agalioti T; Stathopoulos GT
    J Clin Invest; 2015 Jun; 125(6):2317-34. PubMed ID: 25915587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment.
    Zaynagetdinov R; Sherrill TP; Gleaves LA; McLoed AG; Saxon JA; Habermann AC; Connelly L; Dulek D; Peebles RS; Fingleton B; Yull FE; Stathopoulos GT; Blackwell TS
    Cancer Res; 2015 Apr; 75(8):1624-1634. PubMed ID: 25691457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.